Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

World Allergy Week 2020 will address allergy care during the COVID-19 pandemic


World Allergy Week 2020 logo

Allergists can help ease patients’ concerns by identifying the differences between allergies and COVID-19, making health assessments, and reviewing treatment plans.

World Allergy Organization (WAO) will host World Allergy Week from June 28 to July 4, 2020, to emphasize the importance of maintaining regular care of allergies and asthma during the COVID-19 pandemic.

COVID-19, short for “coronavirus disease 2019”, is a disease spreading around the world caused by infection with a new strain of coronavirus (SARS-CoV-2). Patients with symptoms are very contagious, but even those with mild or no symptoms can still infect others. A vaccine against COVID-19 is not yet available.

A pandemic can be a time of anxiety for those with asthma and allergies such as allergic rhinitis (hay fever), eczema/dermatitis, allergic conjunctivitis, food allergies, and other conditions. Symptom similarity between allergies and COVID-19 can be confusing. Sneezing and itching, for example, are common in allergic rhinitis, while fever, fatigue, and shortness of breath appear in COVID-19. Allergists can help ease patients’ concerns by identifying the differences between allergies and COVID-19, making health assessments, and reviewing treatment plans.

“It is important that individuals do not stop taking their prescribed allergy or asthma medications, including inhaled or oral corticosteroids and other asthma controller medications – with or without a pandemic,” according to Sandra N. González-Díaz, MD, PhD, of Universidad Autónoma de Nuevo León in México. “They should consult their physicians about getting the care they need while limiting their exposure to the virus.” In many areas, health care practitioners use telemedicine and telephone consults for non-emergencies to avoid the risk of infection from face-to-face medical visits.

If you have asthma, continuing to control it could help you better defend against the virus. According to Bryan Martin, DO, of The Ohio State University in Columbus, Ohio, USA. “Most respiratory viruses are common triggers of severe asthma attacks. When you have asthma, underlying swelling and inflammation in the lungs can make it difficult to fight off viruses. Taking prescribed controller therapy daily, whether you have symptoms or not, helps repair that inflammation and fight off viruses more efficiently.”

Allergy care might change for patients infected with COVID-19, so it is important that they contact their physicians to discuss their symptoms as soon as possible. According to Motohiro Ebisawa, MD, PhD, of Sagamihara National Hospital in Sagamihara, Japan, and President of the World Allergy Organization. “Professional help is essential to understanding what is causing symptoms such as shortness of breath, chest tightness, or difficulty breathing. Patients should not assume these symptoms are either from their asthma or COVID-19 but consult their physicians immediately in case emergency care is needed.”

The international medical community agrees there is much to understand yet about COVID-19 and the best treatment for those who have become sick. World Allergy Week 2020 organizers are emphasizing the need for patients and physicians alike to stay updated on accurate medical information about COVID-19 and allergic disease and communicate regularly for optimal symptom management, disease prevention, and quality of life.

International allergy experts will present “COVID-19 and Allergic Diseases” a two hour-webinar with a live question and answer session, hosted by WAO on July 2, 2020. It will begin at 8:00 AM EDT (New York). Click here to find your local time: https://www.timeanddate.com/worldclock/converter-classic.html. Find details about the WAO webinar and registration and other resources at: http://www.worldallergyweek.org.

To find an allergy/immunology member society of the World Allergy Organization in your country or region, visit: http://www.worldallergy.org/about-wao/member-societies.

About the World Allergy Organization

The World Allergy Organization (WAO) is an international alliance of 103 regional and national allergy, asthma and immunology societies. Through collaboration with its Member Societies WAO provides a wide range of educational and outreach programs, symposia and lectureships to allergists/immunologists around the world and conducts initiatives related to clinical practice, service provision, and physical training in order to better understand and address the challenges facing allergists/immunologists worldwide. (http://www.worldallergy.org)

Share article on social media or email:

SupplyPro Announces the Put Your Money Where Your Mask Is Sales Promotion


SupplyPro Popular SupplyBay

“We are literally putting our money where customers need it most – PPE Vending,” said Stan Sigman, Chief Revenue Officer.

The Covid-19 pandemic has had an undeniable impact on the way we work. Worker safety is a top priority. Establishing a safe environment and compliant workforce is critical in in the post-Covid world.

To help our partners get back to work quickly and safely, SupplyPro is offering its popular SupplyBay vending machine below cost for a limited time only.

“We are literally putting our money where customers need it most – PPE Vending,” said Stan Sigman, Chief Revenue Officer. “We have gotten a lot of calls from customers who are looking to put everything from safety masks to latex gloves and sanitizer in the machines.” He went on to say, “Automated vending reduces human contact and every transaction is recorded – which increases accountability and benefits contact tracing.”

Taking action now, while the economy is still ramping back up, is the ideal time to position both industrial distributors and their customers for success – SAFELY. Essential safety supplies are dispensed to – the right people, at the right time, where it’s needed most. And compliance is documented to reduce risk and liability in this new environment.

SupplyPro is contributing to help get businesses back to work.

About SupplyPro – Headquartered in San Diego, California, SupplyPro is the leading provider of automated inventory management technologies, with a device-driven, cloud-based ecosystem that seamlessly meshes with most internal ERP systems and distributor delivery solutions. More than 1.8 million monthly users, from manufacturing to aerospace and high-tech fabrication, rely on the SupplyPro platform to increase efficiencies, profitability and competitiveness. For more information visit: http://supplypro.com/.

Share article on social media or email:

Charles E. Crutchfield III, MD and Crutchfield Dermatology Celebrates its 2,000th Virtual Telemedicine Visit


News Image

Charles E. Crutchfield III, M.D.

“If these first 2,000 encounters have taught us anything, it will be that our workflows may change, but more efficient care and widespread quality dermatologic care can be the result. That is our silver lining,” Dr.Crutchfield ended.

Charles E. Crutchfield III, M.D., a national leader in telemedicine and clinical dermatology, announced that he had personally conducted more than 2,000 virtual patient teledermatology visits and consultations last week at Crutchfield Dermatology. So far, telemedicine has proven to be a critical resource as the organization continues to serve patient needs despite ongoing disruptions caused by COVID-19. Dr. Crutchfield is still seeing patients in-office for acute cases that need personal attention. Many patients have opted for virtual telemedicine visits for initial screenings, follow-up appointments, and medicine refills. Additionally, Crutchfield Dermatology can service many small towns and rural areas in northern Minnesota that don’t have a dermatologist. “This is significantly raising the quality of dermatologic care for all of Minnesota citizens,” commented Darrin Rosha, a University of Minnesota Regent. We are also looking to participating in the Medical License Compact that allows a physician to be licensed and serve patients in 27 states. This ability to help patients in 27 states will be an incredible breakthrough, especially for states that don’t have access to a board-certified dermatologist.

“Crutchfield Dermatology is committed to providing high-quality skincare during this challenging time,” said Tim Quesnell, Clinic Manager at Crutchfield Dermatology. “We have created access to telemedicine across all of our offices so that patients can call their provider’s office and get an appointment, along with instructions on an easy-to-use platform for video conferencing. The most important thing we can do for our patients is to make sure they have access to care in the safest place for them, which, still, is their home right now.”

All a patient needs is a computer or smart device, an email address, and basic computer skills. Assistance and instructional help can be provided by the computer-savvy Crutchfield Dermatology staff, as needed. Crutchfield Dermatology supports Zoom, Skype, Google Duo, and several other live virtual platforms.

Charles E. Crutchfield III, M.D., Medical Director of Crutchfield Dermatology reports: “The accelerated development of this critical telemedicine offering is a testament to the nimble, multitalented staff here, and I couldn’t be prouder of the way we rose to the challenge and pushed to adapt for the benefit of our patients, our employees, and communities across the country.” He continued, “This unfortunate situation has brought the opportunity to recalibrate how we provide care. If these first 2,000 encounters have taught us anything, it will be that our workflows may change, but more efficient care and widespread quality dermatologic care can be the result. That is our silver lining,” Dr.Crutchfield ended.

About Charles E. Crutchfield III, M.D:

Charles E. Crutchfield III, M.D., is a graduate of the Mayo Clinic Medical School and a Clinical Professor of Dermatology at the University of Minnesota Medical School. He is currently the Medical Director of Crutchfield Dermatology in Eagan and is a Benedict Distinguished Professor of Biology at Carleton College. Dr. Crutchfield has won numerous teaching and professional awards and is the co-author of a children’s book on sun protection, a dermatology textbook, and hundreds of medial articles. He is a member of the AΩA National Medical Honor Society, an expert consultant for WebMD and CNN, and a recipient of the Karis Humanitarian Award from the Mayo Clinic School of Medicine. He is the team physician for the Minnesota Twins, Vikings, Wild, Timberwolves and Lynx professional sports teams. Dr. Crutchfield has over 25 years of clinical experience caring for patients.

Share article on social media or email:

Houston-Based imaware™ Collaborate with University Researchers to Understand Differences in Patient Vulnerabilities with COVID-19


imaware.health

imaware™, a Houston-based digital health platform organization, is collaborating with university researchers to understand differences in individual risk factors for COVID-19 and target them for early intervention and antiviral therapies. The initial priority of the research project is to understand why a portion of the patient population infected with COVID-19 are at a higher risk for becoming critically ill and how the virus spreads from infected individuals to members of their households.    

Sample collection is underway through the imaware™ healthcare professional-administered in-home testing process. All testing is conducted by a CLIA-certified laboratory using the CDC’s EUA-authorized test and protocol, and healthcare professionals are dispatched to patients’ homes to collect the samples for testing. During a sample collection, the same professional who performs the COVID-19 nasopharyngeal swab takes additional nasal swab samples, where investigators dive into understanding more about the spread of COVID-19 and the virus that causes it.

One aspect of the study is to understand host responses to virus complications caused by an overabundance of cytokines, which are proteins the body uses to fight viruses and infections. These cytokines, when functioning properly, rid the body of illness, but if not functioning properly, can trigger an over-exuberant inflammatory response leading to lung injury, organ failure and other severe complications with potentially deadly results.

Dr. Rebecca Fischer, an infectious disease expert and epidemiologist and laboratory scientist at the Texas A&M University School of Public Health, is also studying transmission in infected persons to others in their household. After a patient receives a positive diagnosis for COVID-19, her team contacts them to request permission to follow their journey, as well as track the spread of the virus within the household. Dr. Fischer gathers information from patients about the duration of their infections and their predispositions to reinfection. By identifying infected and uninfected individuals and collecting multiple samples at multiple time points in these individuals, critical information can be gleaned about the biology of the disease and its progression.

“As patient advocates, we want to aid in the search to understand more about why some patients are more vulnerable than others to the deadly complications of COVID-19. Our current sample collection process is an efficient way to provide longitudinal prospectively driven data for research and to our knowledge, is the only such approach that is collecting, assessing, and biobanking specimens in real time,” said imaware™ Cofounder Jani Tuomi.

Patient samples are stored at Texas A&M University and are invaluable to further study of the virus. At this time, they are interested in speaking with all infected individuals, but in the future, they may narrow the scope to a more targeted approach, as they adapt to what they learn through the research. These samples and data will be a rich resource for additional future studies to understand COVID-19 and SARS-Cov-2.

As part of the imaware™ testing process, the Wheel network contacts patients testing positive as well as provides telemedicine oversight and post-diagnosis care to CODID-19 patients.

“We believe strongly in supporting this research, as findings from the field can be implemented to improve clinical processes– helping even more patients,” said Wheel’s Executive Medical Director, Dr. Rafid Fadul.

# # #

About imaware™

imaware™ is a Houston, Texas based digital health platform organization, offering access to advanced and precise testing that empowers individuals with remote screening and monitoring of their health. imaware™ is uniquely positioned to serve in response to the COVID-19 pandemic by offering access to CDC’s EUA-authorized COVID-19 testing by partnering with a network of local and national healthcare organizations and a CLIA-certified laboratory.

Media Contacts:

Alicia Whitley – Account Supervisor

Lou Hammond Group, Houston

aliciaw@louhammond.com

281.794.4972

Jani Tuomi – Cofounder

imaware™

jani@imaware.health

1.855.502.9273

Share article on social media or email:

Greenberg Traurig’s David Dykeman, Ginger Pigott and Libretta Stennes Speak on DeviceTalks Tuesday Panel


David J. Dykeman, Ginger Pigott and Liberetta Stennes of global law firm Greenberg Traurig, LLP will be participating as panelists on a DeviceTalks Tuesday online panel discussion titled, “How COVID-19 is creating new IP and litigation challenges for medtechs” on June 16, 2020.

The June 16th event will discuss topics such as:

  • IP strategy for companies innovating new technology or forming new collaborations
  • Liability risks and immunity protections
  • Impact of COVID-19 on litigation in the medtech industry

According to DeviceTalks’ website, the panel will provide information for entrepreneurs, investors, startup executives, medtech makers, design professionals, business development managers and anyone who wants to better understand how COVID-19 is affecting the med tech industry. In addition to Dykeman, Pigott, and Stennes, the panel will also include Jeff Mann, Senior Vice President, General Counsel and Secretary of Cantel Medical.

DeviceTalks, according to its website, is a “series of peer-led meetings created to help medtechs most innovative professionals find the quickest way to clear troublesome bottlenecks.”

Dykeman, who serves as co-managing shareholder of Greenberg Traurig’s Boston office and co-chairs the firm’s global Life Sciences & Medical Technology Group, is a registered patent attorney with more than 23 years of experience in patent and intellectual property law. His practice focuses on securing worldwide intellectual property protection and related business strategy for high tech clients, with particular experience in life sciences, medical devices, robotics, materials, and information technology.

Pigott, a shareholder in Greenberg Traurig’s Los Angeles office, is vice chair of the Pharmaceutical, Medical Device & Health Care Litigation Practice and focuses her practice on products liability litigation with an emphasis on the defense of complex medical device and pharmaceutical products. She handles high-stakes, single-plaintiff cases (including through trial) and complex litigation, including MDLs, coordinated state actions and class actions working as both national and regional counsel. She also works with companies to reduce and eliminate litigation risk and has been instrumental in achieving early resolution by way of alternative dispute resolution and dispositive motions in a number of cases.

Stennes, a shareholder in Greenberg Traurig’s Minneapolis office, litigates complex disputes, representing clients on matters related to environmental and mass tort defense, products liability and commercial disputes for clients in the food, agribusiness, chemical and life science industries. She guides clients through complex issues that arise from chemical exposures from products or environmental releases, particularly under emerging regulation.

About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.

About Greenberg Traurig’s Pharmaceutical, Medical Device & Health Care Litigation Group: The Pharmaceutical, Medical Device & Health Care Litigation Group is an integral part of the firm’s 600+ attorney Litigation Practice. Led by “trial wizard” Lori G. Cohen, this team is nationally recognized for its dynamic courtroom presence, responsiveness to clients, and deep subject matter knowledge. Recent recognitions include the shortlist for Benchmark Litigation’s 2020 “Product Liability Firm of the Year”; national rankings for 2019 “Product Liability & Mass Torts” from Chambers USA Guide; and national rankings for 2019 “Product Liability, Mass Tort and Class Action Defense: Pharmaceuticals and Medical Devices” from The Legal 500 United States.

About Greenberg Traurig’s Litigation Practice: Greenberg Traurig’s Litigation Practice includes a team of more than 600 attorneys. The firm’s trial lawyers regularly appear in state and federal courts throughout the country, as well as in appellate courts and before international arbitration panels. They work closely with in-house counsel to develop a strategy that best fits a litigation cost and proficiency model appropriate to the client’s unique needs and goals.

About Greenberg Traurig, LLP: Greenberg Traurig, LLP (GT) has approximately 2200 attorneys in 41 locations in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law.

Share article on social media or email:

Portable, Vehicle-Mounted Hand-Washing Station From National Fleet Products Makes Hygiene Compliance Mobile


COVID-19, PPE, hand sanitizer

Now, water and hand sanitizer can be dispensed virtually anywhere, and application-specific hardware enables units to stand on their own, or to be mounted to a wide variety of vehicles.

Our versatile mobile hygiene station will be a game changer, making hand-washing more accessible and convenient and helping to reduce the spread of COVID-19. – Steven Peterson

National Fleet Products, a global source for aftermarket accessories for commercial vehicles, announced the introduction of its new portable and vehicle-mounted hand-washing stations. The rugged, purpose-built product design allows water and hand sanitizer to be dispensed virtually anywhere, and application-specific hardware enables units to stand on their own, or to be mounted to a wide variety of vehicles.

The President’s Coronavirus Guidelines for America lists hand-washing first under its guidelines for practicing good hygiene. However, until now, it has been difficult for vehicle operators, work crews and others functioning in isolated conditions to observe what the Centers for Disease Control and Prevention (CDC) calls “one of the most important steps we can take to avoid getting sick and spreading germs to others.”

The black or translucent white water-dispensing tanks come in 6.5 gallon and 10 gallon sizes and are made of durable, virgin polypropylene with an additive that makes them resistant to UV rays. An integrated removable soap dispenser serves as the cap to the filling port, and a separate cap is also available.

Spring-toggle water spigots are easy to operate, and because they automatically stop water flow when no longer depressed, they eliminate recontamination because there is no need to touch them again once hands are clean. The spigots are recessed and side mounted to protect them from damage.

Portable units are available with sturdy, powder-coated steel frame stands that can be outfitted with additional accessories such as paper towel dispensers, graphic signage and more. Vehicle-mounted units are available with frame- and body-mounting hardware that is compatible with virtually any type of truck, including heavy-, medium- and light-duty pickups, work trucks, box vans, ag and construction equipment, trailers and more.

“Our versatile mobile hygiene station will be a game changer, making hand-washing more accessible and convenient and helping to reduce the spread of COVID-19,” Steven Peterson, president of National Fleet Products, said. “These cleansing stations can go virtually anywhere and will now enable all sorts of businesses to protect their workers and their customers from transmitting disease.”

Now, workers who share tools and equipment can regularly clean their hands to reduce cross contamination with colleagues. The new units meet Occupational Safety and Health Administration (OSHA) requirements for hand-washing stations at construction sites and can easily be positioned and repositioned as the need arises.

The vehicle-mounted hygiene station enables drivers and crews to sanitize their hands before reentering the vehicle. The system also allows workers and others to avoid unnecessary exposure to hand-washing fixtures in public restrooms, often recognized as key vectors for disease exposure and transmission.

“I had one municipal solid waste fleet tell me that they are excited to have such a versatile sanitizing solution, because they want to keep their people working, but they want to keep them safe in the process,” Peterson said. “Our new portable and vehicle-mounted hand-washing stations help establish new behaviors and reinforce better, more health-conscious habits.”

National Fleet Products’ new portable hand-washing stations can be located at warehouse shipping and receiving doorways, at manufacturing and commercial building points of entry, near fixed and portable restroom facilities, adjacent to food production stands, on construction project sites and at agriculture production and processing facilities. The vehicle-mounted hand-washing stations can go anywhere the vehicle goes.

Parties interested in scheduling a demonstration of the new portable and vehicle-mounted hand-washing stations may contact National Fleet Products directly by calling (763) 762-3451 or by sending an email to sales@nationalfleetproducts.com. The new portable and vehicle-mounted hand-washing stations are in stock now and available in the United States and Canada through the company’s extensive distribution network of convenient distribution locations. Please contact National Fleet Products to locate a distributor near you.

To access high-resolution product images of the new portable and vehicle-mounted hand-washing stations, please visit https://www.nationalfleetproducts.com/water-tanks-media-links.

About National Fleet Products

National Fleet Products is a leading North American supplier of aftermarket accessories for commercial vehicles, including loading ramps, vehicle-mounted hoist systems, ladder racks, truck and trailer fenders, exterior vehicle security locks, suspension assist spring kits and mobile hygiene equipment. The family-owned company serves as a North American master distributor for renowned European product lines such as Jonesco Plastics, WM System, MAD Tooling and Serrature Meroni. The company serves the United States and Canada through its extensive distribution network. Learn more at https://www.nationalfleetproducts.com.

Share article on social media or email:

ASDSA and ASLMS Partner to Develop Guidance for Cosmetic Dermatology Practices During COVID-19


While dermatology practices have always implemented safety measures to minimize infections, the evolving COVID-19 pandemic has created uncertainties and questions for cosmetic dermatologists, some of which we hope can be dispelled by this new resource.

The American Society for Dermatologic Surgery Association (ASDSA) and American Society for Laser Medicine & Surgery (ASLMS) have partnered to produce, “Guidance for Cosmetic Dermatology Practices During COVID-19.” This evidence-based document uses existing literature and studies to drive reopening recommendations as governing authorities allow businesses to reopen.

“While dermatology practices have always implemented safety measures to minimize infections, the evolving COVID-19 pandemic has created uncertainties and questions for cosmetic dermatologists, some of which we hope can be dispelled by this new resource,” said ASDSA Past President and Task Force Co-chair Murad Alam, MD, MBA. “Each recommendation in the guidance includes a grade of evidence and strength of recommendation based on the GRADE framework, along with explanatory text to help dermatologists make the best decision for their specific clinical circumstances.”

Task force members and authors of the guidance include:

  • Shanthi Narla, MD
  • Murad Alam, MD, MBA, Co-chair
  • David M. Ozog, MD, Co-chair
  • Vince Bertucci, MD,
  • Henry Hin Lee Chan, MD, PhD, MRCP
  • Mitchel Goldman, MD
  • Edward Ross, MD
  • David Sliney, PhD
  • Marc D. Brown, MD, ASDSA President
  • Thomas E. Rohrer, MD, ASLMS President

“The authors have produced recommendations and options dermatologists should consider – with literature references to support each recommendation – in regards to mask use for patients, physicians and staff; handwashing protocol; size of procedure room; air suction/HEPA filter use during procedures; germicidal ultraviolet (GUV) use; forced air-cooling during laser procedures; and additional considerations with lower levels of evidence,” said Task Force Co-chair David M. Ozog, MD. “The changing landscape will be evaluated regularly, and the task force will update the guidance as needed to ensure dermatologists can continue providing premium care in the safest environment possible.”

“Patient safety and high standards of clinical care are at the core of our Societies’ missions. Now more than ever, patients are seeking expertise in cosmetic procedures and are looking for treatment plans that cater to their unique needs,” said ASLMS President Thomas Rohrer, MD. “These safety recommendations will help ASDSA and ASLMS members meet this growing demand when they reopen their practices. This document delves into the science behind all of the recommendations being made for safe reopening.”

Visit http://bit.ly/DermReopeningGuidance to access the full guidance document.

About ASDSA

With a membership of 6,400+ physicians, the American Society for Dermatologic Surgery Association (ASDSA) is a 501(c) (6) association, dedicated to education and advocacy on behalf of dermatologic surgeons and their patients. For more information, visit asds.net/ASDSA.

Follow @ASDSAdvocacy on Facebook, Twitter, Instagram and LinkedIn!

About ASLMS

The American Society for Laser Medicine and Surgery, Inc. (ASLMS) is the largest multidisciplinary professional organization dedicated to the development and application of lasers and related technology for health care applications. ASLMS promotes excellence in patient care by advancing biomedical application of lasers and other related technologies worldwide. ASLMS membership includes physicians, surgeons, nurses and allied health professionals representing multiple specialties, physicists involved in product development, biomedical engineers, biologists, industry representatives and manufacturers. For more information, visit http://aslms.org.

Share article on social media or email:



Tipton Health’s Webinar Series Continues with a Special Discussion on Race, Inclusive Practices and Nursing


At this crucial time of important public debate on systemic racism, Tipton Health Communications will host a free nursing leadership webinar on June 24 that will explore race, inclusive practices, and nursing.

Ena Williams, senior vice president and chief nursing officer at Yale New Haven Hospital, will lead a conversation with Ernest Grant, PhD, RN, FAAN, president of the American Nurses Association, and Martha A. Dawson, DNP, RN, FACHE, president of the National Black Nurses Association.

For more information and to register, please visit tiptonhealth.com/webinars.

A Discussion on Race, Inclusive Practices and Nursing

June 24, 12:30–1:15 p.m. EDT

Moderator:

Ena Williams, MBA, MSM, BSN, RN, CENP, Senior Vice President and Chief Nursing Officer, Yale New Haven Hospital

Panelists:

Ernest Grant, PhD, RN, FAAN, President, American Nurses Association

Martha A. Dawson, DNP, RN, FACHE, President, National Black Nurses Association

For more information on upcoming webinars and the experts leading them, please visit tiptonhealth.com/webinars. Here you can also view recordings of our past sessions.

About Tipton Health Communications

Tipton Health Communications is a leading provider of executive nurse consulting and mentoring; nursing excellence program development; and Magnet®, Pathway to Excellence® and Practice Transition Accreditation Program™ consulting support to the nation’s hospital and healthcare systems. In addition, Tipton Health supports clients nationwide with award-winning communications services, including employee communications, human resources communications, public relations, marketing communications, intranet and Internet design, graphic design, and strategic communications. For more information, please visit tiptonhealth.com.

Share article on social media or email:

MaxBusiness; the first MaxLiving Business Intensive Chiropractic Seminar


MaxBusiness is a business intensive event geared toward the chiropractor looking to evolve from a solid diagnostician, into a true business leader! We are offering several tracks and breakout sessions to meet the balanced business needs of your profession. Learn how the industry leaders build a lasting legacy balancing principle, passion, AND profits using the Maxliving health delivery system.

With the current 2020 events creating difficult situations for small business owners and restricting traveling options, we wanted to extend an invitation to join us virtually. Use the link below to register for this growth-focused event today.

To show our support through these trying times, we’ve created the promo code, listed below, so that you may register completely free of charge.

MaxBusiness June 19th – 20th

Link: http://www.maxliving.com/events/virtual-maxbusiness

Promo Code: VIRTUALFREE

If you are not a MaxLiving Chiropractor, and interested in MaxLiving partnership, and other wholesale product opportunities, contact Emily Pugh-Oliver, MaxLiving Customer Sales Manager, at emily.oliver@maxliving.com.

For press information and media resources, please contact Ray Leake, MaxLiving, at (321) 939-3060, or ray.leake@maxliving.com

_______________________________________

MaxLiving is a natural healthcare organization founded on five core principles of wellness. The 5 Essentials® is a natural and effective way to maximize your health by integrating core chiropractic, mindset, nutrition, exercise and oxygen, and minimizing toxin exposure. Our purpose is to be THE Standard for Natural Healthcare. We are a movement of chiropractors revolutionizing the human experience. Our vitalistic health delivery system identifies cause, removes interference, and restores function. MaxLiving exists to transform lives by providing training, educational seminars, partner programs, franchise opportunities, and nutritional products and services. We want to educate the world about the power of chiropractic care and empower people to live a healthy, balanced lifestyle.

Share article on social media or email:

The National Pediculosis Association Calls for A Critical Review of the Centers for Disease Control’s Website Information on Lice


Parents need to know before returning their children to school and other group settings that the health advice they receive is comprehensive and reliable.

The National Pediculosis Association (NPA) is a not-for-profit organization whose mission is to promote the health and wellness of children regarding pediculosis (head lice infestation) through consistent public health messaging, community preparedness, cooperation and trust. The NPA appreciates the complexity of these times as the challenges of the COVID-19 pandemic affect every area of our lives. As restrictions begin to lift, we are all considering how to resume previous activities as responsibly and safely as possible. In this context, the NPA wants to help minimize pediculosis as an additional public health burden when children return to school, summer camp and other group settings.

To this end, the NPA has reviewed the educational information regarding head lice posted on the Centers for Disease Control and Prevention’s (CDC) website. The CDC website is relied upon by parents, health professionals, school administrators and policy makers as an authoritative source of public health information and guidance. Earlier this month, the NPA submitted a commentary to CDC outlining a number of concerns about its website information on head lice. The NPA letter suggested improvements and offered its assistance in order to make CDC’s guidance more thorough and useful to parents and others.

This is especially important in the COVID-19 era. Parents need to know before returning their children to school and other group settings that the health advice they receive is comprehensive and reliable. Those whose children have chronic conditions such as asthma, diabetes, and allergies, for example, must feel confident that their children’s medical needs will not be overlooked while attention is concentrated on preventing the spread of the virus. In this very challenging environment, pediculosis (itself a prevalent communicable disease) need not become an additional burden and disruption.

The NPA recommends its No Nit Policy as a high standard for educating the community before head lice outbreaks occur, empowering parents to send their children to school free of lice and nits.

The COVID-19 pandemic is presenting a learning experience for all of us. We have choices as to how we move forward. It would be ideal that when children return to school it will be with all the necessary safeguards in place.

Share article on social media or email: